Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Sean Whooley

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Inquis Medical completes enrollment in IDE study of thrombectomy system

By

Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system. The FDA investigational device exemption (IDE) trial evaluates the safety and efficacy of Aventus for the treatment of pulmonary embolism (PE). Aventus features proprietary tissue-sensing technology. It provides operators … [Read more...] about Inquis Medical completes enrollment in IDE study of thrombectomy system

Medtronic inks stent distro deal with Contego with option to buy

By

Medtronic (NYSE: MDT)announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical. Under the agreement, Medtronic serves as the sole U.S. distributor for Contego's portfolio of commercially available products. Raleigh, North Carolina-based Contego offers products that provide revascularization treatment for … [Read more...] about Medtronic inks stent distro deal with Contego with option to buy

Johnson & Johnson MedTech wins CE mark for dual-energy catheter

By

Johnson & Johnson MedTech [WtwhTicker symbol="JNJ"](NYSE: JNJ)[/WtwhTicker] announced today that it received CE mark approval for its dual-energy ThermoCool SmartTouch SF catheter. The irrigated, contact-force sensing catheter features alongside the TruPulse generator. Both offer full integration with the Carto 3 electro-anatomical mapping … [Read more...] about Johnson & Johnson MedTech wins CE mark for dual-energy catheter

Johnson & Johnson MedTech halts Varipulse cases due to stroke reports

By

Johnson & Johnson MedTech announced today that it "temporarily paused" all U.S. cases using its Varipulse pulsed field ablation (PFA) system as of Jan. 5. "Out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and all U.S. Varipulse cases while we investigate the root cause of four … [Read more...] about Johnson & Johnson MedTech halts Varipulse cases due to stroke reports

AerWave completes first-in-human study of lung denervation tech

By

AerWave announced today that it completed the first-in-human feasibility study of its disease-modifying ultrasound lung denervation therapy. New York-based AerWave also raised $12 million to further advance its therapy for chronic obstructive pulmonary disease (COPD) and asthma. The ultrasound platform aims to simplify and enhance lung … [Read more...] about AerWave completes first-in-human study of lung denervation tech

Boston Scientific makes IVL play with Bolt Medical acquisition

By

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular lithotripsy (IVL) platform developer Bolt Medical. On a 100% basis — before considering an existing equity stake and other adjustments — the deal is valued at $600 million upfront with up to an additional $300 million upon achievement of certain regulatory … [Read more...] about Boston Scientific makes IVL play with Bolt Medical acquisition

Francis Medical raises $80M Series C for water vapor ablation tech

By

Francis Medical announced today that it completed an oversubscribed $80 million Series C equity financing. Arboretum Ventures and Solas BioVentures co-led the Series C round. New investors Orlando Health Ventures and two additional strategic partners also joined in the round. Existing investors Coloplast A/S and Tonkawa participated, … [Read more...] about Francis Medical raises $80M Series C for water vapor ablation tech

Xeltis completes enrollment in vascular access conduit study

By

Xeltis announced today that it completed enrollment in an EU pivotal trial for aXess, its restorative vascular access conduit. The study evaluates aXess in adults with end-stage renal disease. Eindhoven, The Netherlands-based Xeltis will conduct the study in 120 subjects across 22 centers in Europe. This study follows 12-month data from a … [Read more...] about Xeltis completes enrollment in vascular access conduit study

Endologix picks former Medtronic executive as new CEO

By

Endologix announced today that President and CEO Dr. Matt Thompson intends to step down and take on a new role. Thompson plans to transition into the position of EVP and chief medical officer. As a result, the company appointed Dr. John Liddicoat as its new president and CEO, effective immediately. Richard Mott, Endologix's board chair, said … [Read more...] about Endologix picks former Medtronic executive as new CEO

NanoVibronix completes pilot study for UroShield device

By

NanoVibronix (Nasdaq:NAOV) announced today that it completed the first phase of a randomized controlled trial for its UroShield device. Researchers at the University of Michigan completed the first phase of the trial for UroShield, a portable ultrasonic therapeutic device. UroShield utilizes patented low-intensity surface acoustic wave (SAW) … [Read more...] about NanoVibronix completes pilot study for UroShield device